<DOC>
	<DOC>NCT01120509</DOC>
	<brief_summary>The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.</brief_summary>
	<brief_title>Crux Biomedical Vena Cava Filter Study - United States</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Patient has a permanent or temporary risk of Pulmonary Embolism Patient or legal guardian must provide written informed consent At least one of the following conditions Proven PE Recurrent PE despite adequate anticoagulation Contraindication to anticoagulation Inability to achieve/maintain therapeutic anticoagulation Iliocaval DVT Large, freefloating proximal DVT Massive PE treated with thrombolysis/thrombectomy Chronic PE treated with thrombectomy Procetion during thrombolysis for iliocaval DVT PE with limited cardiopulmonary reserve Poor compliance with anticoagulation medication High risk of injury worsend by anticoagulation Multitrauma patient with high risk of PE Surgical patients at high risk of PE Medical condition with high risk of PE Patient has documented vena cava diameter of 1728mm Patient has IVC anatomy suitable for infrarenal placement Patient willing to be available for the appropriate follow up. Age &lt;18 years old Patient has any one of the following conditions Renal vein thrombosis IVC thrombosis extending to te renal veins Duplicate IVC Gonadal vein thrombosis Requires suprarenal placement Uncontrolled infectious disease Risk of aseptic PE Uncontrolled coagulopathy Existing inferior vena cava filter implant Life expectancy less than 6 months Pregnant or planning a pregnancy in the next 6 months Condition that inhibits radiographic visualization of the IVC Known allergy or intolerance to polytetrafluoroethylene (PTFE) or Nitinol Known hypersensitivity to contract which cannot be pretreated Access vessels preclude safe insertion of delivery system Participation in another drug or device trial Unable or unwilling to cooperate with study procedures or required followup visits</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Vena Cava</keyword>
	<keyword>Vena Cava Filter</keyword>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Risk of Pulmonary Embolism</keyword>
</DOC>